AIA
AMAG

Affinity Investment Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Affinity Investment Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,747
Closed -$220K – 197
2017
Q1 		$220K Buy
9,747
+3,310
+51% +$79.2K 0.02% 174
2016
Q4 		$224K Buy
+6,437
New +$192K 0.02% 146

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Affinity Investment Advisors's AMAG Position: Q2 2017 in Review

Affinity Investment Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 9,747 shares — an estimated $220K sold.

Affinity Investment Advisors first reported a position in AMAG in Q4 2016 and held it in 2 quarters. The position peaked at $224K in Q4 2016. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • Affinity Investment Advisors reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Affinity Investment Advisors sold 9,747 AMAG Pharmaceuticals shares in Q2 2017, an estimated $220K.
  • Affinity Investment Advisors first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 2 quarters.
  • Affinity Investment Advisors's AMAG Pharmaceuticals position peaked at $224K in Q4 2016.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Affinity Investment Advisors's 13F filing for Q2 2017, filed 25 Jul 2017.